Financial Performance - Total net revenue for the three months ended March 31, 2025, was $15.6 million, a decrease of approximately $9.9 million or 39% compared to $25.4 million in the same period of 2024[96] - Gross margin for the three months ended March 31, 2025, was negative $0.3 million, representing (2)% of net revenue, a decrease from $8.5 million or 33% of net revenue in the same period of 2024[99] - New orders for the three months ended March 31, 2025, totaled $15.7 million, a decrease of $4.1 million or 21% from $19.8 million in the same period of 2024[98] - Cash provided by operating activities for the six months ended March 31, 2025, was $3.1 million, down from $5.3 million in the same period of 2024[116] - Cash used in investing activities was $0.2 million for the six months ended March 31, 2025, compared to $0.7 million provided in the same period of 2024[117] - Cash provided by financing activities was $0.1 million for the six months ended March 31, 2025, primarily from stock option exercises, contrasting with $6.4 million used in the same period of 2024[118] Backlog and Working Capital - The backlog as of March 31, 2025, was $19.1 million, a decrease of $25.2 million or 57% compared to $44.3 million in 2024[98] - Working capital decreased to $37.4 million as of March 31, 2025, from $44.8 million as of September 30, 2024[114] - Unrecorded purchase obligations decreased to $5.2 million as of March 31, 2025, from $12.1 million as of September 30, 2024[120] Expenses - Research and development expenses for the three months ended March 31, 2025, were 5% of net revenue, compared to 4% in the same period of 2024[94] - Selling, general and administrative expenses for the three months ended March 31, 2025, were $7.1 million, a decrease from $8.3 million in the same period of 2024[102] - RD&E expenses for the six months ended March 31, 2025, decreased to $1.7 million from $2.5 million in the same period of 2024, reflecting a reduction in strategic-development project expenditures[104] Impairments - Goodwill impairment recognized during the six months ended March 31, 2025, totaled $20.4 million, with $15.4 million from the Semiconductor Fabrication Solutions segment and $5.0 million from the Thermal Processing Solutions segment[105] - Intangible asset impairment for the six months ended March 31, 2025, amounted to $2.6 million, recorded within operating expenses[107] Cash and Cash Equivalents - Cash and cash equivalents increased to $13.4 million as of March 31, 2025, from $11.1 million at the beginning of the period[113] Tax Rate - The effective tax rate for the six months ended March 31, 2025, was (2.3%), compared to (3.5%) for the same period in 2024, influenced by foreign income taxation and non-deductible expenses[111] Strategic Initiatives - The acquisition of Entrepix in 2023 enhanced the company's offerings in the CMP technology space and integrated wafer cleaning into existing product lines[90] - The company plans to continue pursuing organic growth alongside acquisitions to bolster its market position[92] - The introduction of the next-generation reflow platform, Aurora, is part of the company's ongoing investment in research and development[90] - The company is focusing on supply chain resiliency by expanding operations outside of mainland China, which is expected to create demand for new equipment and services[91]
Amtech Systems(ASYS) - 2025 Q2 - Quarterly Report